This year saw a return to major industry events. Highlights included attending BioPharma PM, BioIT World, and BIO conferences and showcasing our Pipeline Program Management software. We launched a successful “Roadmap Informatics & Laboratory Planning Service” and completed significant client projects, including Diagnostics LIMS System, DEL Library Design & Screening, and Automated Synthesis modules.
Year in Review | Aspen Biosciences Read More »
Aspen Biosciences has continued to grow over the last quarter with the addition of 7 new team members, to help with the explosive demand for custom applications, and integrated systems in the drug discovery and diagnostics industries. These new team members bring the company size up to 70. Throughout this year, the Aspen Biosciences teams have also made meaningful improvements to existing products such as Pharm2Market and Pipeline while beginning development on Delos, a new application coming soon to the Biotechnology industry.
Aspen Biosciences: Expanding Team to Meet Industry Demand Read More »
San Diego Entrepreneurs Exchange (SDEE) What led up to starting Aspen Biosciences?I was working for Royal Dutch Shell (Shell) in the Netherlands when my mom and grandmother were diagnosed with pancreatic cancer. That’s when I became interested in Biotech. Searching for information about pancreatic cancer while waiting at the hospital, I realized how little we
Interview with a Member: Spotlight Read More »
Pharm2Market introduces premier SAAS application for the biotech industry SAN DIEGO, CALIFORNIA, March 29, 2021 – The team at Aspen Biosciences has officially announced the launch of Pharm2Market 2.0, which offers a feature-rich upgrade from its predecessor. In December 2018, Aspen Biosciences launched Pharm2Market as a SAAS (software as a service) solution offering information on
Press Release: Aspen Biosciences Unveils Pharm2Market 2.0 Read More »
My mother’s love for books mirrored the nation’s renewed interest in Defoe’s “A Journal of the Plague Year” during the COVID-19 pandemic. This year highlighted the rapid development of mRNA therapeutics, innovative drug discovery, and our community efforts to support those affected by the crisis.
Aspen Biosciences: A Year of Innovation, Adversity, and Community Engagement Read More »
Throughout this unprecedented year, Aspen Biosciences supported the biotech/pharma industry by providing safe return-to-work strategies and unbiased technology solutions. We assisted companies in selecting and optimizing ELN and LIMS systems, ensuring custom, efficient solutions through a collaborative, agile development process tailored to their specific needs.
Aspen Biosciences: Supporting Biotechnology and Pharmaceuticals in 2020 Read More »
As the country reopens, biotech companies navigate the new normal. They seek solutions for essential on-site personnel, productivity, and safe collaboration. Common strategies include hybrid work models, improved lab protocols, and increased use of virtual tools. Continuous evaluation ensures safety and efficiency.
Biotech Companies Adapting to COVID-19 Challenges: Strategies and Solutions Read More »
Pharm2Market 1.0, released in December 2018, expanded in 2019 with growing users and databases like San Francisco’s. The upcoming Pharm2Market 2.0, set for Q1 2020, brings enhanced features like iPhone support, autocuration, and richer queries for improved performance and usability.
Pharm2Market 2.0: Enhanced Performance and Access Pass Subscription | Q1 2020 Release Read More »
